VetSheet

コデイン

Codeine

Codeine phosphate, Codeine sulfate

オピオイド作動薬 / 鎮痛薬 / 鎮咳薬POIMIVSC小型哺乳類

別名: Tylenol with Codeine · Empirin with Codeine · Pardale-V · Co-codamol (human combination) · Codeine phosphate hemihydrate · Codeini phosphas hemihydricus · Codeinii phosphas · Codeinum · Methylmorphine · Codeine sulfate

VetSheet 獣医チームが監修更新日 2026年4月5日エビデンスに基づく獣医学リファレンス

監査済み v13 用量エビデンス

構造化された用量計算エビデンス

Antitussive (extra-label)

1–2 mg/kgPO

認証済み獣医師の確認が必要

  • q6-12h

NA

必ず考慮する臨床コンテキスト (2)
  • ■ This medicine may be given with food or on an empty stomach.
  • Store codeine sulfate tablets in light-resistant, well-closed containers at room temperature 15°C to 30°C (59°F-86°F).
規制薬認証済み獣医師の確認が必要formularyプロトコル 2023監査 dose-audit-plumb-v13

用量は獣医専門家向けの臨床参考資料です。必ず最新の医薬品情報および個別症例に基づいて確認してください。

診察中ですか?VetSheet の AI が薬剤・用量・投与期間を構造化された診察記録に直接記入します。VetSheet の仕組みを見る

概要

​コデイン​はフェナントレン誘導体のオピオイド作動薬であり、獣医学では主に​鎮咳薬​(咳止め)および軽度の​鎮痛薬​として使用されます。止瀉薬として使用されることもあります。

  • ​鎮痛​:軽度から中等度の疼痛に使用され、NSAIDsが無効または禁忌の場合によく用いられます。
  • ​鎮咳​:非生産性の咳(気管虚脱、慢性気管支炎など)の抑制に非常に有効です。
  • ​止瀉​:消化管の運動を低下させます。

​臨床上のポイント​:人医療では広く使用されていますが、犬での使用には議論があります。犬は経口コデインの吸収が非常に悪く、活性代謝物(モルヒネ)に変換するための強力な酵素経路を欠いています。そのため、犬における鎮痛効果は非常にばらつきがあり、一般的にブプレノルフィンやメタドンなどの他のオピオイドに劣ると考えられています。

作用機序

Codeine acts as a weak agonist at mu (μ) opioid receptors.

  • Analgesia: Binds to ​μ-receptors​ in the central nervous system → inhibits the release of excitatory neurotransmitters (such as Substance P) in ascending pain pathways → alters the perception of and response to pain.
  • Antitussive: Causes direct depression of the medullary cough center in the brainstem.
  • Antidiarrheal: Binds to enteric μ-receptors → decreases gastrointestinal motility and increases sphincter tone.
  • Metabolism Note: In humans, codeine is a prodrug metabolized by the enzyme CYP2D6morphine. Dogs lack significant CYP2D6-equivalent activity, relying mostly on codeine-6-glucuronide for any analgesic effect, which explains its limited efficacy in this species.

安全性・警告

禁忌

  • Hypersensitivity to narcotic analgesics
  • Patients receiving monoamine oxidase inhibitors (MAOIs) like amitraz or selegiline
  • Diarrhea caused by toxic ingestion (until toxin is eliminated)
  • Repeated use in severe inflammatory bowel disease
  • Scorpion stings (Centruroides sculpturatus and C. gertschi) as it may potentiate venom
  • Combination products containing acetaminophen are STRICTLY CONTRAINDICATED in cats
  • Hypersensitivity to opioids
  • Severe respiratory depression or asthma
  • Cats (especially if using combination products containing paracetamol)

有害事象

  • Sedation (most common)
  • Constipation
  • Anorexia
  • Vomiting
  • Ileus
  • Biliary and pancreatic duct spasms
  • Respiratory depression (at high doses)
  • Cats: CNS stimulation, hyperexcitability, tremors, seizures
  • Nausea

注意事項

Use with caution in patients with hypothyroidism, severe renal insufficiency, Addison's disease, and in geriatric or severely debilitated patients.

Use with caution in patients with head injuries or increased intracranial pressure, and in those with acute abdominal conditions (e.g., colic) as it may obscure the diagnosis.

Use with extreme caution in patients suffering from respiratory disease or acute respiratory dysfunction (e.g., pulmonary edema secondary to smoke inhalation).

Warning: Opiates can increase plasma amylase and lipase values up to 24 hours following administration due to increased biliary tract pressure.

医薬品相互作用

Anticholinergic drugs

May increase the chances of constipation developing

Antidepressants (TCAs/MAOIs)

May potentiate CNS depressant effects

CNS Depressants (anesthetics, antihistamines, phenothiazines, barbiturates, tranquilizers)

May cause increased CNS or respiratory depression

Quinidine

May inhibit the transformation of codeine to morphine in the liver, decreasing its efficacy

CNS Depressants (e.g., phenobarbital, diazepam)Moderate

Additive CNS and respiratory depression

SSRIs / MAOIsMajor

Increased risk of serotonin syndrome

CNS Depressants (e.g., sedatives, anesthetics, antihistamines)Major

Additive CNS and respiratory depression

Monoamine Oxidase Inhibitors (MAOIs)Major

May cause severe, unpredictable reactions (serotonin syndrome or severe respiratory depression)

監視

  • Efficacy (pain relief, reduction in coughing, or resolution of diarrhea)
  • Adverse effects (sedation, respiratory rate, GI signs)
  • Respiratory rate and depth
  • Level of sedation
  • Pain score or coughing frequency
  • Bowel movements (monitor for constipation)

薬物動態

半減期

Unknown1 - 2 hours

吸収

Very limited evidence of oral absorption in dogs. In humans, codeine salts are rapidly absorbed orally, with oral administration being about 2/3 as effective as parenteral. Onset of action is usually within 30 minutes.

分布

Crosses the placenta and enters maternal milk.

代謝

Metabolized in the liver.

消失

Excreted into the urine.

過剰投与

Opiate overdosage may produce profound respiratory and/or CNS depression. Other effects can include cardiovascular collapse, hypothermia, and skeletal muscle hypotonia.

  • Decontamination: Oral ingestions should be removed using standard gut removal protocols. Inducing vomiting should be attempted with caution due to rapid changes in CNS status.
  • Antidote: Naloxone is the agent of choice for treating respiratory depression. In massive overdoses, naloxone doses may need to be repeated, as its effects may diminish before subtoxic levels of codeine are attained.
  • Supportive Care: Mechanical respiratory support should be considered in cases of severe respiratory depression. Contact an animal poison control center for further guidance.

製品

製剤

  • Tablets
  • Oral solution/elixir
  • Parenteral injection
  • Combination products (with acetaminophen, aspirin, or guaifenesin)
  • 3 mg/5 ml paediatric linctus
  • 3 mg/ml linctus
  • 5 mg/ml syrup
  • 15 mg tablet
  • 30 mg tablet
  • 60 mg tablet

動物用医薬品

  • Pardale-V tablets (Combination: Paracetamol 400 mg + Codeine phosphate 9 mg)

ヒト用医薬品

  • Codeine Phosphate Solution: 15 mg/5 mL
  • Codeine Sulfate Tablets: 15 mg, 30 mg & 60 mg
  • Codeine Phosphate Parenteral Injection: 15 mg/mL & 30 mg/mL
  • Codeine Phosphate Antitussives with expectorants (e.g., with guaifenesin)
  • Codeine Phosphate with Acetaminophen tablets (Tylenol® with Codeine #1, #2, #3, #4)
  • Codeine Phosphate with Aspirin tablets (Empirin® with Codeine #2, #3, #4)
  • Codeine linctus (3 mg/ml, 3 mg/5 ml)
  • Codeine syrup (5 mg/ml)
  • Codeine tablets (15 mg, 30 mg, 60 mg)

規制ステータス

European Union✓ 承認済み処方箋医薬品 · Controlled DrugEMA
🐕 Dogs

Availability of veterinary specific products varies by member state.

United Kingdom✓ 承認済み処方箋医薬品 · Schedule 2 (pure codeine) or Schedule 5 (low dose combinations/linctus)VMD
🐕 Dogs

Classified as POM-V or POM depending on the specific product (e.g., Pardale-V is POM-V).

規制データなし: 🇺🇸 US · 🇭🇰 HK · 🇹🇼 TW · 🇯🇵 JP · 🇰🇷 KR · 🇦🇺 AU

保管・安定性

Codeine phosphate and sulfate tablets should be stored in light-resistant, well-closed containers at room temperature. Codeine phosphate injection should be stored at room temperature (avoid freezing) and protected from light. Do not use the injection if discolored or if it contains a precipitate.

飼主向け情報

  • ​子供やペットの手の届かないところに保管してください​:これは規制薬物です。
  • ​猫に対する毒性​:アセトアミノフェンを含む製品(例:Tylenol® with Codeine)は​絶対に​猫に与えないでください。急速に死に至る危険があります。
  • ​副作用​:極度の眠気、便秘、食欲不振、嘔吐に注意してください。猫は時折、異常に活動的になったり、神経質になったり、震えたりすることがあります。
  • ​獣医師への連絡のタイミング​:行動や活動レベルの重大な変化、または重度の胃腸症状が見られた場合は、直ちに獣医師に報告してください。

VetSheet医薬品リファレンスは獣医専門家の臨床意思決定支援を目的としており、専門的判断または製造業者の最新医薬品情報の代替にはなりません。